XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Cumulative Distributions in Excess of Earnings
Cumulative Other Comprehensive Loss
Total Equity
Noncontrolling Interests
Columbia Operating Partnership
Noncontrolling Interests
Consolidated Joint Venture
Beginning balance, value at Dec. 31, 2018 $ 2,741,016 $ 1,167 $ 4,421,587 $ (1,684,082) $ 2,344      
Beginning balance, shares at Dec. 31, 2018   116,698,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued to employees and directors, and amortized (net of income tax withholdings) (858) $ 2 (860)          
Common stock issued to employees and directors, and amortized (net of income tax withholdings), shares   182,000            
Distributions to common stockholders (23,376)     (23,376)        
Net income 3,513     3,513        
Market value adjustments to interest rate swaps that qualify for hedge accounting treatment (1,431)       (1,431)      
Ending balance, value at Mar. 31, 2019 2,718,864 $ 1,169 4,420,727 (1,703,945) 913      
Ending balance, shares at Mar. 31, 2019   116,880,000            
Beginning balance, value at Dec. 31, 2019 $ 2,628,617 $ 1,153 4,392,322 (1,769,234) (1,101) $ 2,623,140   $ 5,477
Beginning balance, shares at Dec. 31, 2019 115,280,597 115,280,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Repurchases of common stock $ (23,276) $ (12) (23,264)     (23,276)    
Repurchases of common stock, shares   (1,194,000)            
Issuance of noncontrolling interest in Columbia Operating Partnership 55,306           $ 55,306  
Common stock issued to employees and directors, and amortized (net of income tax withholdings) 2,458 $ 3 97     100 2,358  
Common stock issued to employees and directors, and amortized (net of income tax withholdings), shares   327,000            
Distributions to common stockholders (24,175)     (24,175)   (24,175)    
Contributions from noncontrolling interest in consolidated joint venture 16             16
Distributions to consolidated joint venture partner and Operating Partnership Unit holders (794)           (685) (109)
Net income 6,228     6,290   6,290 71 (133)
Market value adjustments to interest rate swaps that qualify for hedge accounting treatment (19,993)       (19,408) (19,408) (585)  
Ending balance, value at Mar. 31, 2020 $ 2,624,387 $ 1,144 $ 4,369,155 $ (1,787,119) $ (20,509) $ 2,562,671 $ 56,465 $ 5,251
Ending balance, shares at Mar. 31, 2020 114,413,205 114,413,000